The 12-16-week open-label study evaluated Ruxoprubart as monotherapy in treatment-naïve PNH patients. Key findings include: CLEVELAND, March 09, 2026 (GLOBE NEWSWIRE) -- NovelMed Therapeutics Inc., a ...

Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...

Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...

Arizona's lawyer shortage hurts everyone. Adding more practice-based law schools here will protect the growing population's needs for representation.

Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES, February 27, 2026 /EINPresswire.com/ — ...

Arizona's lawyer shortage hurts everyone. Adding more practice-based law schools here will protect the growing population's ...

ABA Committee Urges Inclusion of Alternative Licensure Pathways Language in Accreditation Standards The Standards Committee reviewed Standard 316 in light of the recent developments that several U.S.

Aberrant complement activation can cause damage to newly formed fetal-derived structures and excessive inflammatory response at the feto-maternal interface, contributing to pregnancy-related ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...

LONE TREE, Colo. — As fewer people go to school to be teachers and many leave the profession altogether, school districts are turning to alternative pathways to bring new teachers into classrooms. "I ...